Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-29 06:11 am Sale |
2024-12-31 | 13G | Electrovaya Inc. ELVA |
HIRSCHMAN ORIN | 2,515,099 6.300% |
-838,209 (-25.00%) |
Filing History |
| 2025-01-29 06:08 am Purchase |
2024-12-31 | 13G | Arq, Inc. ARQ |
HIRSCHMAN ORIN | 3,012,956 7.200% |
674,220 (+28.83%) |
Filing History |
| 2025-01-27 10:07 am Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 2,022,221 4.900% |
-640,103 (-24.04%) |
Filing History |
| 2025-01-23 3:34 pm Sale |
2024-12-31 | 13G | BK Technologies Corporation BKTI |
HIRSCHMAN ORIN | 268,180 7.500% |
-62,716 (-18.95%) |
Filing History |
| 2025-01-21 11:57 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
HIRSCHMAN ORIN | 2,717,827 6.100% |
2,717,827 (New Position) |
Filing History |
| 2024-11-08 4:51 pm Sale |
2024-11-05 | 13G | Delcath Systems, Inc. DCTH |
HIRSCHMAN ORIN | 1,472,312 4.600% |
-67,326 (-4.37%) |
Filing History |
| 2024-10-29 7:47 pm Unchanged |
2024-10-29 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-09 5:19 pm Purchase |
2024-10-01 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 6,737,932 9.300% |
4,403,264 (+188.60%) |
Filing History |
| 2024-10-09 4:05 pm Sale |
2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
HIRSCHMAN ORIN | 0 0.000% |
-1,061,509 (Position Closed) |
Filing History |
| 2024-09-17 7:30 pm Sale |
2024-06-14 | 13G | IN8bio, Inc. INAB |
HIRSCHMAN ORIN | 2,334,668 4.990% |
-1,763,693 (-43.03%) |
Filing History |
| 2024-08-19 06:03 am Purchase |
2024-08-16 | 13G | Personalis, Inc. PSNL |
HIRSCHMAN ORIN | 4,394,064 6.700% |
1,394,064 (+46.47%) |
Filing History |
| 2024-07-26 12:56 pm Purchase |
2024-07-19 | 13G | Personalis, Inc. PSNL |
HIRSCHMAN ORIN | 3,000,000 5.800% |
3,000,000 (New Position) |
Filing History |
| 2024-07-16 06:02 am Sale |
2024-07-15 | 13G | Red Cat Holdings, Inc. RCAT |
HIRSCHMAN ORIN | 3,000,000 4.000% |
-2,026,104 (-40.31%) |
Filing History |
| 2024-06-11 4:05 pm Sale |
2024-06-10 | 13G | KWESST Micro Systems Inc. KWE |
HIRSCHMAN ORIN | 0 0.000% |
-55,618 (Position Closed) |
Filing History |
| 2024-06-05 07:26 am Purchase |
2024-05-09 | 13G | Plus Therapeutics, Inc. PSTV |
HIRSCHMAN ORIN | 568,681 9.900% |
568,681 (New Position) |
Filing History |
| 2024-05-30 08:42 am Purchase |
2024-05-16 | 13G | Arq, Inc. ARQ |
HIRSCHMAN ORIN | 2,338,736 6.500% |
2,338,736 (New Position) |
Filing History |
| 2024-04-09 09:13 am Purchase |
2024-03-25 | 13G | Ideal Power Inc. IPWR |
HIRSCHMAN ORIN | 700,000 9.500% |
700,000 (New Position) |
Filing History |
| 2024-04-09 08:49 am Purchase |
2024-03-25 | 13G | Intellicheck, Inc. IDN |
HIRSCHMAN ORIN | 1,598,953 8.200% |
1,598,953 (New Position) |
Filing History |
| 2024-04-09 08:46 am Purchase |
2024-03-27 | 13G | Acasti Pharma Inc. ACST |
HIRSCHMAN ORIN | 567,812 6.000% |
567,812 (New Position) |
Filing History |
| 2024-03-25 9:52 pm Sale |
2024-03-22 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 0 0.000% |
-2,040,540 (Position Closed) |
Filing History |